Madely Health Headlines Commentary for March 1, 2010

 

 Disease-modifying drug reduces brain protein plaques in Alzheimer patients: Play Now | Play in Popup | Download

Source:

Neuroimaging technique shows potential of bapineuzumab treatment and might be useful in assessing other drugs for Alzheimer’s Disease

Reference:

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Related articles:

1. Small phase 1 study shows electrical stimulation of the brain can help slow progression of Alzheimer Disease
2. Observational data supports Mediterranean diet reduces Alzheimer risk
3. Medication reduces bleeding-related deaths after trauma
4. Progress in understanding how aging contributes to the development of Alzheimer Disease
5. Cognitive fitness and innovative therapies may thwart the development of Alzheimer Disease